Table 1 Clinical data in the studied groups

Age (years) mean ± SD

65.0 ± 9.0

69.0 ± 9.5

68.0 ± 9.0

0.32

Male/female n

22/18

20/10

18/12

0.62

Rural/urban n

18/22

15/15

16/14

0.49

Risk factors n (%)

 Diabetes mellitus

26 (65.0)

18 (60.0)

22 (73.3)

0.54

 Hypertension

18 (45.0)

14 (46.7)

14 (46.7)

0.99

 Hyperlipidemia

14 (35.0)

18 (60.0)

20 (66.7)

0.018

 Obesity

12 (30.0)

8 (26.7)

4 (13.3)

0.32

 Cardiac disease

20 (50.0)

14 (46.7)

12 (40.0)

0.71

 Smoking

18 (45.0)

10 (33.3)

10 (33.3)

0.50

 Drug abuse

8 (20.0)

4 (13.3)

10 (33.3)

0.26

 Stroke

20 (50.0)

20 (66.7)

16 (53.3)

0.36

 Homocystinemia

18 (45.0)

16 (53.3)

20 (66.7)

0.20

Clinical findings n (%)

 Dizziness

4 (10.0)

–

–

0.044

 Dysphasia

8 (20.0)

4 (13.3)

–

0.038

 Headache

6 (15.0)

2 (6.7)

–

0.069

 Left ataxic hemiparesis

4 (10.0)

10 (33.3)

–

0.001

 Left hemihypothesis

6 (15.0)

2 (6.7)

–

0.069

 Right hemiparesis

–

6 (20.0)

14 (46.7)

 < 0.001

 Left hemiparesiss

–

4 (13.3)

12 (40.0)

 < 0.001

 Tinnitus

6 (15.0)

–

–

0.008

 Unsteadiness

6 (15.0)

2 (6.7)

4 (13.3)

0.55

Treatment n (%)

 Regular treatment

34 (85.0)

30 (100.0)

30 (100.0)

0.008

 rTPA

6 (15.0)

–

–

Hospital stay (days) mean ± SD

9.2 ± 2.8

8.1 ± 1.9

7.7 ± 3.1

0.053

Outcome n (%)

 Favorable

10 (25.0)

11 (36.7)

13 (43.3)

0.84

 Unfavorable

16 (40.0)

15 (50.0)

15 (50.0)

Mortality n (%)

14 (35.0)

4 (13.3)

2 (6.7)

0.007